These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 17116299

  • 21. Influence of light cycle on response to 5-HT1A ligands in punished responding in rats.
    Gleason SD, Leander JD.
    Behav Pharmacol; 1999 Dec; 10(8):785-91. PubMed ID: 10780294
    [Abstract] [Full Text] [Related]

  • 22. Testosterone promotes anxiolytic-like behavior in gonadectomized male rats via blockade of the 5-HT1A receptors.
    Fedotova J, Hritcu L.
    Gen Comp Endocrinol; 2017 Dec 01; 254():14-21. PubMed ID: 28919453
    [Abstract] [Full Text] [Related]

  • 23. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
    Sun YN, Wang T, Wang Y, Han LN, Li LB, Zhang YM, Liu J.
    Neuropharmacology; 2015 Aug 01; 95():181-91. PubMed ID: 25797491
    [Abstract] [Full Text] [Related]

  • 24. Dorsomedial hypothalamus serotonin 1A receptors mediate a panic-related response in the elevated T-maze.
    Nascimento JO, Kikuchi LS, de Bortoli VC, Zangrossi H, Viana MB.
    Brain Res Bull; 2014 Oct 01; 109():39-45. PubMed ID: 25290207
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A behavioral mechanistic investigation of the role of 5-HT1A receptors in the mediation of rat maternal behavior.
    Li X, Ding X, Wu R, Chen L, Gao J, Hu G, Li M.
    Pharmacol Biochem Behav; 2018 Jun 01; 169():16-26. PubMed ID: 29649502
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.
    Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E.
    J Pharm Pharmacol; 2003 Apr 01; 55(4):533-43. PubMed ID: 12803776
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar 01; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 31. Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide.
    Solinas M, Tanda G, Wertheim CE, Goldberg SR.
    Psychopharmacology (Berl); 2010 Apr 01; 209(2):191-202. PubMed ID: 20179908
    [Abstract] [Full Text] [Related]

  • 32. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
    Kõks S, Beljajev S, Koovit I, Abramov U, Bourin M, Vasar E.
    Psychopharmacology (Berl); 2001 Jan 01; 153(3):365-72. PubMed ID: 11271409
    [Abstract] [Full Text] [Related]

  • 33. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP, Jackson DM, Wallsten C, Waszczak BL.
    J Pharmacol Exp Ther; 1999 Feb 01; 288(2):820-6. PubMed ID: 9918594
    [Abstract] [Full Text] [Related]

  • 34. Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist.
    Gu B, Wu G, Si J, Xu Y, Andersson KE.
    Neurourol Urodyn; 2012 Jan 01; 31(1):168-73. PubMed ID: 21780177
    [Abstract] [Full Text] [Related]

  • 35. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb 01; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 36. 5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes.
    Sempere T, Urbina M, Lima L.
    Neuroimmunomodulation; 2004 Feb 01; 11(5):307-15. PubMed ID: 15316241
    [Abstract] [Full Text] [Related]

  • 37. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW, Ogilvie J, Houghton AK.
    Br J Pharmacol; 1997 Oct 01; 122(4):631-8. PubMed ID: 9375958
    [Abstract] [Full Text] [Related]

  • 38. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.
    Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C.
    Neuropsychopharmacology; 2006 Feb 01; 31(2):247-55. PubMed ID: 16012533
    [Abstract] [Full Text] [Related]

  • 39. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
    Guenther U, Manzke T, Wrigge H, Dutschmann M, Zinserling J, Putensen C, Hoeft A.
    Anesth Analg; 2009 Apr 01; 108(4):1169-76. PubMed ID: 19299781
    [Abstract] [Full Text] [Related]

  • 40. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.
    Neuroscience; 2010 Aug 11; 169(1):229-35. PubMed ID: 20423722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.